C. Migotto

Human Cytomegalovirus (HCMV)-Specific CD4+ and CD8+ T Cells Are Both Required for Prevention of HCMV Disease in Seropositive Solid-Organ Transplant Recipients

M. Furione, D. Lilleri, G. Gerna, 2014, PloS one.

Virologic and Immunologic Monitoring of Cytomegalovirus to Guide Preemptive Therapy in Solid‐Organ Transplantation

E. Arbustini, M. Furione, D. Lilleri, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Kinetics of T-Lymphocyte Subsets and Posttransplant Opportunistic Infections in Heart and Kidney Transplant Recipients

F. Baldanti, C. Tinelli, A. de Silvestri, 2012, Transplantation.

Hemodialysis vascular access: everything you always wanted to know about it (but were afraid to ask).

C. Esposito, M. Torreggiani, V. Esposito, 2013, Journal of nephrology.

The improvement of ischemia/reperfusion injury by erythropoetin is not mediated through bone marrow cell recruitment in rats.

F. Grosjean, C. Esposito, F. Mangione, 2009, Transplantation proceedings.

Effects of continuous erythropoietin receptor activator (CERA) in kidney transplant recipients.

F. Grosjean, C. Esposito, M. Torreggiani, 2012, Transplantation proceedings.

Increased asymmetric dimethylarginine serum levels are associated with acute rejection in kidney transplant recipients.

C. Tinelli, F. Grosjean, C. Esposito, 2009, Transplantation proceedings.